Pakistani NGO workers protest at a rally on World AIDS Day in Peshawar in 2006.
Tariq Mahmood/AFP/Getty Images
August 19, 2011 HIV isn't openly discussed in Middle Eastern societies. New data give a much clearer picture of its prevalence and how governments do and don't respond. We speak with one researcher who explains the challenges of studying a topic taboo in the region.
August 3, 2011 The number of people infected with HIV each year is relatively steady, at about 50,000 new infections each year. But there was a 48 percent increase in the number of young HIV-infected African American men who have sex with men from 2006 to 2009.
A study of Ugandans found antiretroviral drugs can extend the lifespans of people with HIV to nearly normal lengths.
Adek Berry/AFP/Getty Images
July 19, 2011 Women on treatment outlive men, probably because men start treatment later, a study finds. But the success of HIV treatment in extending people's lives is far greater than many expected when antiviral drugs were first rolled out in Africa less than a decade ago.
<iframe src="http://www.npr.org/player/embed/138490855/138499993" width="100%" height="290" frameborder="0" scrolling="no">
Bottles of antiretroviral drug Truvada, a medicine used in trials that showed a reduction in transmission of HIV between heterosexuals.
Justin Sullivan/Getty Images
July 14, 2011 Results from studies conducted in Africa confirm that drugs against HIV can reduce the risk of transmission of the virus between heterosexual partners. But where and with whom should the approach be used?
May 26, 2011 Findings from a recent study suggest that if all the HIV-infected people in the world got antiviral drugs, the 30-year-old pandemic could be brought to heel. Now the administration's chief AIDS strategist is leading a what-if discussion about that tack.
May 12, 2011 Early treatment of the HIV-infected person with antiretroviral drugs cut the risk of HIV transmission to his or her uninfected sexual partner by 96 percent. The effect was so dramatic, an international study was halted four years early.
<iframe src="http://www.npr.org/player/embed/136242769/136253936" width="100%" height="290" frameborder="0" scrolling="no">
HIV viral particles as seen under an electron microscope.
Dr. A. Harrison and Dr. P. Feorino/CDC
April 11, 2011 Ending a ban on transplants of HIV-positive organs could help HIV patients get kidneys and livers. About 500 people a year could benefit, according to an analysis from Johns Hopkins researchers.
Elizabeth Taylor testifies before a U.S. Senate committee in 1986, after the death of close friend Rock Hudson in 1985.
Stephen Ferry/Getty Images
March 23, 2011 Taylor's legacy as an early, outspoken advocate for people infected with HIV will live on.
March 2, 2011 The agency crunched data from 26 randomized controlled trials, the gold standard in clinical tests, and decided they do not show an increased risk of heart attacks.
Sales of Gilead's Truvada pill against HIV aren't getting a boost from data that show it can prevent infection.
February 28, 2011 Sales of a drug to treat HIV haven't showed a big increase since a study showed it could also prevent infection. An annual cost around $13,000 could be one reason.
December 1, 2010 Today's a day to pause, reflect and read up on the disease that remains a critical problem around the globe.
<iframe src="http://www.npr.org/player/embed/131722223/131722347" width="100%" height="290" frameborder="0" scrolling="no">
August 4, 2008 What innovative, effective programs to fight HIV/AIDS are working where you live? ...
NPR thanks our sponsors
Become an NPR sponsor